SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-029505
Filing Date
2014-05-12
Accepted
2014-05-12 15:40:18
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v376775_10q.htm 10-Q 278125
2 EXHIBIT 31.1 v376775_ex31-1.htm EX-31.1 10454
3 EXHIBIT 31.2 v376775_ex31-2.htm EX-31.2 10494
4 EXHIBIT 32.1 v376775_ex32-1.htm EX-32.1 4929
5 EXHIBIT 32.2 v376775_ex32-2.htm EX-32.2 4888
  Complete submission text file 0001144204-14-029505.txt   2807145

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prph-20140331.xml EX-101.INS 318338
7 XBRL TAXONOMY EXTENSION SCHEMA prph-20140331.xsd EX-101.SCH 33605
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prph-20140331_cal.xml EX-101.CAL 24463
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prph-20140331_def.xml EX-101.DEF 160192
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prph-20140331_lab.xml EX-101.LAB 245269
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prph-20140331_pre.xml EX-101.PRE 188883
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 14833270
SIC: 2834 Pharmaceutical Preparations